DÖRING LAB
-
We focus on chemokine(-receptor) biology on leukocytes and vascular cells in cardiovascular diseases.
- We examine cell-specific roles of CXCL12 and its receptors CXCR4 and ACKR3 in chronic arterial vascular inflammation.
- Furthermore, we elucidate how CCR8 impacts on anti-inflammatory immune responses and how the chemokine-like receptor ChemR23 mediates macrophage polarization and vascular immune responses in atherosclerosis.
LATEST NEWS FROM THE LAB
-
CXCL13-CXCR5 dyad, CXCR4 and B cells in atherosclerosis.
Similarly, we could show that expression of the chemokine receptor CXCR4 on B1 cells controls IgM titers and thereby mediated atheroprotection underlining the importance of B1 cell–derived IgM in atheroprotection.
ACKR3 and Dysfunctional adipose tissue
-
GROUP MEMBERS
Yvonne Döring, PhDPrincipal InvestigatorMaria Kral, PhDPostdoctoral researcherYvonne JansenTechnicianAlumniYi Yan, former PostDoc
Selin Gencer, former PhD student
Madeleine Müller, former PhD student
Linsey Peters, former PhD student
Soyolmaa Bayasgalan, former Technical Assistant